Clinical trial · Interventional
Dose-Response Curve: Interventions to Prevent and Treat Radiodermatitis
Use of Chamomilla Recutita Gel and Urea Cream to Prevent and Treat Radiodermatitis: Phase 2 Study
NCT02249884CI-TRIAL-00020000DRCPTRcompletedPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Dose response curve to define the security and tolerable dose to be used for prevention and treatment of radiodermatitis in patients with breast or head and neck cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Radiodermatitis | — | UNRESOLVED | — |
Interventions
Interventions (6)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Chamomile Dose A | Drug | — | UNRESOLVED |
| Chamomile Dose B | Drug | — | UNRESOLVED |
| Chamomile Dose C | Drug | — | UNRESOLVED |
| Urea Dose A | Drug | — | UNRESOLVED |
| Urea Dose B | Drug | — | UNRESOLVED |
| Urea Dose C | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (6)
- type
- EXPERIMENTAL
- label
- Urea Dose A
- description
- Topical application of the urea cream in concentration A. The product should be applied on the skin three times daily over 3 weeks.
- interventionNames
- Drug: Urea Dose A
- type
- EXPERIMENTAL
- label
- Urea Dose B
- description
- Topical application of the urea cream in concentration B. The product should be applied on the skin three times daily over 3 weeks.
- interventionNames
- Drug: Urea Dose B
- type
- EXPERIMENTAL
- label
- Urea Dose C
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Being an adult, over the age of 18 years old * Owning diagnosis of breast or head and neck cancer * Being first referred to the radiotherapy protocol * Have absence of radiodermatitis and integrates skin to start radiotherapy * Not have presented anticipated reaction of hypersensitivity to chamomile or any plant of the family Asteraceae or Compositae or urea. * Demonstrate conditions to continue the intervention in their home environment when needed. Exclusion Criteria: * Medical prescription for the procedure of data collection, some kind of intervention to prevent radiodermatitis.
References
Publications (0)
Data not yet available
No reference posted for this study.